Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 6/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 3/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | LDHB | P07195 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5887367 | 0.89 | PTGDR2 (0.41) | HTR2C | |
| SCHEMBL944179 | 0.85 | APOBEC3G (0.39) | HTR2CCHRNB4CHRNA3IDO1PDPK1 | |
| SCHEMBL105441 | 0.79 | HTR2C (0.35) | HTR2CCHRNB4CHRNA3IDO1PDPK1 | |
| SCHEMBL3425103 | 0.78 | CHRNB4 (0.50) | HTR2CCHRNB4CHRNA3IDO1PDPK1 | |
| SCHEMBL6940509 | 0.78 | CHRNB4 (0.50) | HTR2CCHRNB4CHRNA3IDO1PDPK1 | |
| SCHEMBL2469257 | 0.76 | HTR2C (0.67) | HTR2CHTR1ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL944717 | 0.76 | CETP (0.41) | HTR2CHTR1A | |
| SCHEMBL9883179 | 0.76 | HTR2C (0.41) | HTR2CSLC6A2 | |
| SCHEMBL3539172 | 0.75 | HTR2C (0.51) | HTR2CHTR1ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL944629 | 0.75 | CETP (0.43) | HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119615135-A | Electroless copper plating additive, electroless copper plating solution and electroless copper plating method for IC carrier plate | 深圳市板明科技股份有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-118970164-A | Three-dimensional crosslinked gel polymer electrolyte and preparation method and application thereof | 郑州比克电子有限责任公司 | 2024-11-15 | — | — | CN | claimed |
| CN-113122058-A | Preparation method of ink and quantum dot film | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | claimed |
| US-3968132-A | (17R)-Spiro-[androstane-17,1'-cyclobutan]-2'-ones, methods for their manufacture and intermediates useful therein | SCHERING CORPORATION (US) | 1976-07-06 | — | — | US | claimed |
| CN-120058570-A | Application of metal ion doped graphene oxide film catalytic material in catalyzing thioether oxidation reaction to synthesize sulfone | 中国科学院理化技术研究所 | 2025-05-30 | — | — | CN | disclosed |
| CN-118970164-A | Three-dimensional crosslinked gel polymer electrolyte and preparation method and application thereof | 郑州比克电子有限责任公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-112533934-B | Polyoxometallate compounds exhibiting bright emissions and methods of making same | 纳米2D材料有限公司 | 2024-07-19 | — | — | CN | disclosed |
| CN-113122058-A | Preparation method of ink and quantum dot film | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | disclosed |
| CN-112640182-A | Nonaqueous electrolyte solution and nonaqueous secondary battery | 旭化成株式会社 | 2021-04-09 | — | — | CN | disclosed |
| CN-112533934-A | Polyoxometallate compounds exhibiting bright emission and methods of making the same | 纳米2D材料有限公司 | 2021-03-19 | — | — | CN | disclosed |
| CN-110256307-B | Method for synthesizing sulfoxide compound | 南京雷正医药科技有限公司 | 2021-01-29 | — | — | CN | disclosed |
| CN-103736238-B | Fire extinguishing composition containing sulfur-containing organic compound | 湖北及安盾消防科技有限公司 | 2020-10-13 | — | — | CN | disclosed |
| EP-1341761-A1 | SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS | SMITHKLINE BEECHAM CORPORATION (US) | 2003-09-10 | — | — | EP | disclosed |
| US-20030087902-A1 | Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents | SMITHKLINE BEECHAM CORPORATION | 2003-05-08 | — | — | US | disclosed |
| WO-2002053522-A2 | NOVEL ESTROGEN RECEPTOR LIGANDS AND METHODS I | KARO BIO AB (SE) | 2002-07-11 | — | — | WO | disclosed |
| WO-2002030895-A1 | SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-η BINDING AGENTS | SMITHKLINE BEECHAM CORPORATION (US) | 2002-04-18 | — | — | WO | disclosed |
| EP-0499327-B1 | Steroid compounds active on the cardiovascular system | ZAMBON SPA (IT) | 1996-11-13 | — | — | EP | disclosed |
| US-5426179-A | Substituted androstanes | ZAMBON GROUP S.P.A. (IT) | 1995-06-20 | — | — | US | disclosed |
| EP-0499327-A1 | Steroid compounds active on the cardiovascular system | ZAMBON GROUP S.p.A. (IT) | 1992-08-19 | — | — | EP | disclosed |
| US-3968132-A | (17R)-Spiro-[androstane-17,1'-cyclobutan]-2'-ones, methods for their manufacture and intermediates useful therein | SCHERING CORPORATION (US) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030087902-A1 | Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents | PPARG, PPARA, PPARD | HTR2C 489/4885CHRNB4 2245/4885CHRNA3 1519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.